

Viscosity is a basic, often overlooked biomarker for circulatory health. Blood viscosity is a direct measure of the ability of the blood to flow and is easily modifiable using existing therapies.
The Hemathix Blood Analyzer is a calibrated glass capillary
system used to monitor changes in the amount of solids present
in blood plasma in various disorders.
The Hemathix Blood Analyzer is available to clinical laboratories and researchers based in the U.S.
Test requirements: 3 mL of blood in lavender tube (EDTA), ambient stability 8 hours, refrigerated stability 4 days, frozen specimens unacceptable.
Hyperviscosity syndromes are a well-established class of conditions that can arise in a variety of disease states, including among others polycythemia vera, dysproteinemias, multiple myeloma, leukemia, sickle cell anemia, and sepsis.
Hyperviscosity includes syndromes of serum hyperviscosity where patients may hemorrhage or experience neurologic or ocular disorders; syndromes of polycythemic hyperviscosity that result in reduced blood flow or capillary perfusion and increased organ congestion; and, syndromes of hyperviscosity caused by reduced deformability of red blood cells as in sickle cell anemia.
Kwaan HC, Bongu A. The hyperviscosity syndromes. Semin Thromb Hemost 1999; 25:199-208.